Inicio

REUNIÓN
REGIONAL
TTCC

Jueves, 19 de febrero de 2026

CANTABRIA/NAVARRA/
LA RIOJA/PAÍS VASCO

H.U. de Navarra

Entra en la Web APP

Herramienta informativa
para pacientes y familiares

Descarga la App

Cáncer Cabeza y Cuello

Plataforma Ensayos Clínicos

EVENTOS Y FORMACIÓN

TTCC-GrupoTratamiento Tumores Cabeza y Cuello Follow 3,123 1,251

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello - Spanish Head and Neck Cancer Cooperative Group- 2001

Retweet on Twitter TTCC-GrupoTratamiento Tumores Cabeza y Cuello Retweeted

Oncología Médica | HUN-NOU @OncoMedicaHUN ·

29 Ene 2016976041458249886

👩🏼‍⚕️👨🏻‍⚕️¡Apuntaos! No queda nada! 📝🩺

Reply on Twitter 2016976041458249886 Retweet on Twitter 2016976041458249886 1 Like on Twitter 2016976041458249886 1 Twitter 2016976041458249886

TTCC-GrupoTratamiento Tumores Cabeza y Cuello @ttccgroup ·

29 Ene 2016866277998940490

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus–Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial | Journal of Clinical Oncology

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus–Driven Oropharynx...

PURPOSEPatients with human papillomavirus (HPV)–positive oropharyngeal cancer (OPC) and advanced stage and/or significant ...

ascopubs.org

Reply on Twitter 2016866277998940490 Retweet on Twitter 2016866277998940490 1 Like on Twitter 2016866277998940490 2 Twitter 2016866277998940490

Retweet on Twitter TTCC-GrupoTratamiento Tumores Cabeza y Cuello Retweeted

CA: A Cancer Journal for Clinicians @CACancerJournal ·

13 Ene 2011069497130602565

📣 Just released: @AmericanCancer Cancer Statistics, 2026

For the 1st time, the 5-year survival rate for all cancers combined reached 70% for people diagnosed during 2015-2021 in the United States.

Notable survival gains are also revealed: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70043

@OncoAlert

Reply on Twitter 2011069497130602565 Retweet on Twitter 2011069497130602565 46 Like on Twitter 2011069497130602565 67 Twitter 2011069497130602565

Cargar más

Newsletter

TTCC-GrupoTratamiento Tumores Cabeza y Cuello Follow 3,123 1,251

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello - Spanish Head and Neck Cancer Cooperative Group- 2001

Retweet on Twitter TTCC-GrupoTratamiento Tumores Cabeza y Cuello Retweeted

Oncología Médica | HUN-NOU @OncoMedicaHUN ·

29 Ene 2016976041458249886

👩🏼‍⚕️👨🏻‍⚕️¡Apuntaos! No queda nada! 📝🩺

Reply on Twitter 2016976041458249886 Retweet on Twitter 2016976041458249886 1 Like on Twitter 2016976041458249886 1 Twitter 2016976041458249886

TTCC-GrupoTratamiento Tumores Cabeza y Cuello @ttccgroup ·

29 Ene 2016866277998940490

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus–Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial | Journal of Clinical Oncology

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus–Driven Oropharynx...

PURPOSEPatients with human papillomavirus (HPV)–positive oropharyngeal cancer (OPC) and advanced stage and/or significant ...

ascopubs.org

Reply on Twitter 2016866277998940490 Retweet on Twitter 2016866277998940490 1 Like on Twitter 2016866277998940490 2 Twitter 2016866277998940490

Retweet on Twitter TTCC-GrupoTratamiento Tumores Cabeza y Cuello Retweeted

CA: A Cancer Journal for Clinicians @CACancerJournal ·

13 Ene 2011069497130602565

📣 Just released: @AmericanCancer Cancer Statistics, 2026

For the 1st time, the 5-year survival rate for all cancers combined reached 70% for people diagnosed during 2015-2021 in the United States.

Notable survival gains are also revealed: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70043

@OncoAlert

Reply on Twitter 2011069497130602565 Retweet on Twitter 2011069497130602565 46 Like on Twitter 2011069497130602565 67 Twitter 2011069497130602565

Cargar más

Newsletter

TTCC-GrupoTratamiento Tumores Cabeza y Cuello Follow 3,123 1,251

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello - Spanish Head and Neck Cancer Cooperative Group- 2001

Retweet on Twitter TTCC-GrupoTratamiento Tumores Cabeza y Cuello Retweeted

Oncología Médica | HUN-NOU @OncoMedicaHUN ·

29 Ene 2016976041458249886

👩🏼‍⚕️👨🏻‍⚕️¡Apuntaos! No queda nada! 📝🩺

Reply on Twitter 2016976041458249886 Retweet on Twitter 2016976041458249886 1 Like on Twitter 2016976041458249886 1 Twitter 2016976041458249886

TTCC-GrupoTratamiento Tumores Cabeza y Cuello @ttccgroup ·

29 Ene 2016866277998940490

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus–Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial | Journal of Clinical Oncology

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus–Driven Oropharynx...

PURPOSEPatients with human papillomavirus (HPV)–positive oropharyngeal cancer (OPC) and advanced stage and/or significant ...

ascopubs.org

Reply on Twitter 2016866277998940490 Retweet on Twitter 2016866277998940490 1 Like on Twitter 2016866277998940490 2 Twitter 2016866277998940490

Retweet on Twitter TTCC-GrupoTratamiento Tumores Cabeza y Cuello Retweeted

CA: A Cancer Journal for Clinicians @CACancerJournal ·

13 Ene 2011069497130602565

📣 Just released: @AmericanCancer Cancer Statistics, 2026

For the 1st time, the 5-year survival rate for all cancers combined reached 70% for people diagnosed during 2015-2021 in the United States.

Notable survival gains are also revealed: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70043

@OncoAlert

Reply on Twitter 2011069497130602565 Retweet on Twitter 2011069497130602565 46 Like on Twitter 2011069497130602565 67 Twitter 2011069497130602565

Cargar más

Acuerdo GORTEC

Newsletter

TTCC en cifras

0

Año de Creación

0

Número de Socios

0

Hospitales

TTCC en cifras

Hazte Socio

Entidades Colaboradoras